Abstract
Genitourinary and gynecological malignancies include bladder, prostate, renal cell, uterine, ovarian, cervical, and testicular cancers. These all present differently and symptoms vary among patients. It is estimated that at least 70% of patients have pain syndromes associated with their pathology [Office for National Statistics Cancer statistics registrations: registrations of cancer diagnosed in 2002 England, Series MB1 no. 33. Office for National Statistics, London, 2005]. While pain may be the result of the disease process itself, it may also be the consequence of therapies used when treating malignancies. Furthermore, patients may have pain from sites primarily involved or from distant metastases. The following chapter discusses potential pain syndromes a cancer patient may face and how techniques and paradigms in pain management strategies can improve the patient’s pain symptoms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Office for National Statistics Cancer statistics registrations: registrations of cancer diagnosed in 2002 England. Series MB1 no. 33. London: Office for National Statistics, 2005.
Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
Ali M, et al. Anatomy of the pelvic plexus and innervation of the prostate gland. Clin Anat. 2004;17(2):123–9.
Eman A, Serbülent G, Gürcü ME. Pain management in prostate cancer. Open J Urol. 2012;2(3):164.
Bader P, et al. Prostate cancer pain management: EAU guidelines on pain management. World J Urol. 2012;30(5):677–86.
Autio KA, et al. Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure. J Oncol Pract. 2013;9(5):223–9.
Khosla A, Adeyefa O, Nasir S. Successful treatment of radiation-induced proctitis pain by blockade of the ganglion impar in an elderly patient with prostate cancer: a case report. Pain Med. 2013;14:662–6. https://doi.org/10.1111/pme.12065.
Gulati A, Khelemsky Y, Loh J, Puttanniah V, Malhotra V, Cubert K. The use of lumbar sympathetic blockade at L4 for management of malignancy-related bladder spasms. Pain Physician. 2011;14(3):305–10.
Portenoy RK, et al. Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer. 1994;74(3):907–15.
Noronha AF, Mello de Figueiredo E, Rossi de Figueiredo Franco TM, Cândido EB, Silva-Filho AL. Treatments for invasive carcinoma of the cervix: what are their impacts on the pelvic floor functions? Int Braz J Urol. 2013;39(1):46–54.
Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165–76.
Serafini AN. Therapy of metastatic bone pain. J Nucl Med. 2001;42(6):895–906.
Buga S, Sarria JE. The management of pain in metastatic bone disease. Cancer Control. 2012;19(2):154–66.
Birthi P, Sloan P. Interventional treatment of refractory cancer pain. Cancer J. 2013;19(5):390–6.
Hutson N, Hung JC, Puttanniah V, Lis E, Laufer I, Gulati A. Interventional pain management for sacroiliac tumors in the oncologic population: a case series and paradigm approach. Pain Med. 2017;18(5):959–68.
Brejt N, et al. Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge. Cancer Imaging. 2013;13(4):591.
Amr YM, Makharita MY. Neurolytic sympathectomy in the management of cancer pain – time effect: a prospective, randomized multicenter study. J Pain Symptom Manag. 2014;48(5):944–56.
Woo JH, Park HS, Kim SC, Kim YH. The effect of lumbar sympathetic ganglion block on gynecologic cancer-related lymphedema. Pain Physician. 2013;16(4):345–52.
de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain. 2004;110(1):400–8.
Ahmed DG, Mohamad MF, Mohamed SA-E. Superior hypogastric plexus combined with ganglion impar neurolytic blocks for pelvic and/or perineal cancer pain relief. Pain Physician. 2015;18(1):E49–56.
Stogicza A, et al. Inferior hypogastric plexus block affects sacral nerves and the superior hypogastric plexus. ISRN Anesthesiology. 2012;2012:1–5.
Saito T, Den S, Tanuma K, Tanuma Y, Carney E, Carlsson C. Anatomical bases for paravertebral anesthetic block: fluid communication between the thoracic and lumbar paravertebral regions. Surg Radiol Anat. 1999;21(6):359–63.
Mishra S, Bhatnagar S, Rana SP, Khurana D, Thulkar S. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain Med. 2013;14(6):837–42.
Eker HE, Cok OY, Kocum A, Acil M, Turkoz A. Transsacrococcygeal approach to ganglion impar for pelvic cancer pain: a report of 3 cases. Reg Anesth Pain Med. 2008;33(4):381–2.
Elahi, et al. Pudendal entrapment neuropathy: a rare complication of pelvic radiation therapy. Pain Physician. 2013;16:E793–7.
Prologo JD, et al. Percutaneous CT-guided cryoablation for the treatment of refractory pudendal neurologia. Skelet Radiol. 2015;44:709–14.
Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol. 2003;17(3):407–28. Becker R, Sure U, Bertalanffy H. Punctate midline myelotomy a new approach in the management of visceral pain. Acta Neurochir 1999;141(8): 881–883.
Becker R1, Gatscher S, Sure U, Bertalanffy H. The punctate midline myelotomy concept for visceral cancer pain control-case report and review of the literature. Acta Neurochir Suppl. 2002;79:77–8.
Nauta HJW, et al. Punctate midline myelotomy for the relief of visceral cancer pain. J Neurosurg Spine. 2000;92(2):125–30.
Flagg II, Artemus, McGreevy K, Williams K. Spinal cord stimulation in the treatment of cancer-related pain:“back to the origins”. Curr Pain Headache Rep. 2012;16(4):343–9.
Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg Spine. 2004;100(3):254–67.
Baranidharan G, Simpson KH, Dhandapani K. Spinal cord stimulation for visceral pain – a novel approach. Neuromodulation. 2014;17(8):753–8.
Deer TR, et al. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician. 2011;14(3):E283–312.
Bruel BM, Burton AW. Intrathecal therapy for cancer-related pain. Pain Med. 2016;17(12):2404–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Margulis, I., Gulati, A. (2019). Genitourinary Cancer Pain Syndromes. In: Gulati, A., Puttanniah, V., Bruel, B., Rosenberg, W., Hung, J. (eds) Essentials of Interventional Cancer Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-319-99684-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-99684-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99682-0
Online ISBN: 978-3-319-99684-4
eBook Packages: MedicineMedicine (R0)